Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia

被引:25
作者
Babo, Yohannes Demissie [1 ]
Alemie, Getahun Asres [2 ]
Fentaye, Fasil Walelign [3 ]
机构
[1] Management Sci Hlth, Bahirdar, Ethiopia
[2] Univ Gondar, Publ Hlth Inst, Coll Med & Hlth Sci, Gondar, Ethiopia
[3] Wollo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia
来源
PLOS ONE | 2017年 / 12卷 / 11期
关键词
HIV-1-INFECTED ADULTS; VIROLOGICAL RESPONSES; RECOVERY; SUCCESS;
D O I
10.1371/journal.pone.0187694
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Due to the limited availability of viral load testing for treatment outcome monitoring in resource limited settings, identifying predictive factors of antiretroviral treatment failure will help in selecting clients who will benefit most from the targeted use of viral load monitoring. Little is known about the predictors of treatment failure in the study area. This study was conducted to determine factors that predict first-line antiretroviral therapy failure among HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. For this study, antiretroviral therapy treatment failure was defined as the fulfillment of clinical and/or immunological criteria set by WHO. Methods Case-control study was carried out from November to December 2014. Cases were adult clients who were on failing first line regimen and on active follow up while controls were those adult clients on a non-failing first-line regimen for 36 months and above and on active follow up. Data was entered in to Epi Info version 7 and was exported to SPSS version 20 for analysis. Binary logistic regression model was used to identify predictors of ART failure. Results A total of 59 cases and 245 controls were included in the analysis. Sixty three percent of the participants were females and the median age at ART enrollment was 33 years (IQR; 28, 40). The median baseline CD4 count was not significantly different among cases and controls (105 (IQR = 60-174)vs.131 (IQR = 72.5-189.0); p = 0.301). The median peak CD4 count in the failure group (230 (IQR = 123-387)) was significantly low compared to the non-failure group (463 (IQR = 348.5-577)) [p< 0.001]. High peak CD4count (AOR = 0.993; 95% Cl 0.990, 0.996) and longer duration on ART (AOR = 0.923; 95% Cl 0.893, 0.954) were protective of treatment failure. In addition stavudine based regimen (AOR = 3.47; 95% Cl 1.343,10.555), low baseline BMI (AOR = 2.75; 95% Cl 1.012, 7.457), unemployment (AOR = 4.93; 95% Cl 1.493,16.305) and formal educational level (AOR = 5.15; 95% Cl 1.534,17.276) were independently significant predictors of treatment failure. Conclusions In this setting low peak CD4count, shorter duration on first line ART, d4T based regimen, low baseline BMI, unemployment and formal educational level were significantly associated with increased treatment failure. Retaining patients on their initial first line regimen with appropriate follow up and improving their socioeconomic status through various livelihood initiatives should be strengthened.
引用
收藏
页数:19
相关论文
共 45 条
  • [1] Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
    Abdissa, Alemseged
    Yilma, Daniel
    Fonager, Jannik
    Audelin, Anne M.
    Christensen, Lone H.
    Olsen, Mette F.
    Tesfaye, Markos
    Kaestel, Pernille
    Girma, Tsinuel
    Aseffa, Abraham
    Friis, Henrik
    Pedersen, Court
    Andersen, Aase B.
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [2] Ahel D, 2016, PREV GAP REP
  • [3] Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
    Ahoua, Laurence
    Guenther, Gunar
    Pinoges, Loretxu
    Anguzu, Paul
    Chaix, Marie-Laure
    Le Tiec, Clotilde
    Balkan, Suna
    Olson, David
    Olaro, Charles
    Pujades-Rodriguez, Mar
    [J]. BMC INFECTIOUS DISEASES, 2009, 9
  • [4] Amhara HIV/AIDS Prevention and Control Coordination Office, FACTAND FIG
  • [5] [Anonymous], 2012, HIV drug resistance report
  • [6] [Anonymous], 2012, ETH DEM HLTH SURV 20
  • [7] Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
    Anude, Chuka J.
    Eze, Emeka
    Onyegbutulem, Henry C.
    Charurat, Man
    Etiebet, Mary-Ann
    Ajayi, Samuel
    Dakum, Patrick
    Akinwande, Oluyemisi
    Beyrer, Chris
    Abimiku, Alash'le
    Blattner, William
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [8] Anup Singh Anup Singh, 2013, Journal of AIDS and Clinical Research, V4, P210
  • [9] The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study
    Assefa, Abate
    Gelaw, Baye
    Getnet, Gebeyaw
    Yitayew, Gashaw
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [10] Outcomes of antiretroviral treatment program in Ethiopia: Retention of patients in care is a major challenge and varies across health facilities
    Assefa, Yibeltal
    Kiflie, Abiyou
    Tesfaye, Dessalegn
    Mariam, Damen Haile
    Kloos, Helmut
    Wouters, Edwin
    Laga, Marie
    Van Damme, Wim
    [J]. BMC HEALTH SERVICES RESEARCH, 2011, 11